Back to top
Clinical stage:
In-vitro formulation

A family of drugs known as Angiotensin II antagonists, including Losartan and Valsartan, commonly used for the treatment of hypertension. N4 Pharma is seeking to reduce the impact of an early morning drop in blood pressure which is a cause of many cardiac incidents.

Angiotensin II had global annual sales of approximately $11.2 billion in 2016*

*Source: Evaluate Pharma